Literature DB >> 30108940

Exploring eukaryotic versus prokaryotic ribosomal RNA recognition with aminoglycoside derivatives.

Narayana Murthy Sabbavarapu1, Tomasz Pieńko2,3, Bat-Hen Zalman1, Joanna Trylska2, Timor Baasov1.   

Abstract

New derivatives of aminoglycosides containing 6'-carboxylic acid or 6'-amide on their ring I were designed, synthesized and their ability to readthrough nonsense mutations was examined in vitro, along with the protein translation inhibition in prokaryotic and eukaryotic systems. The observed structure-activity relationships, along with the comparative molecular dynamics simulations within the eukaryotic rRNA decoding site, showed high sensitivity of 6'-position to substitution, indicating that the rational design of potent stop-codon read-through inducers requires consideration of not only the structure and energetics of the drug-RNA interaction but also the dynamics associated with that interaction.

Entities:  

Year:  2018        PMID: 30108940      PMCID: PMC6071974          DOI: 10.1039/c8md00001h

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  21 in total

1.  How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.

Authors:  S K Lüdemann; V Lounnas; R C Wade
Journal:  J Mol Biol       Date:  2000-11-10       Impact factor: 5.469

2.  Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA.

Authors:  Klaus B Simonsen; Benjamin K Ayida; Dionisios Vourloumis; Masayuki Takahashi; Geoffrey C Winters; Sofia Barluenga; Seema Qamar; Sarah Shandrick; Qiang Zhao; Thomas Hermann
Journal:  Chembiochem       Date:  2002-12-02       Impact factor: 3.164

3.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

4.  Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.

Authors:  Malvika Kaul; Christopher M Barbieri; Daniel S Pilch
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

5.  Conformational dynamics of bacterial and human cytoplasmic models of the ribosomal A-site.

Authors:  Joanna Panecka; Jiří Šponer; Joanna Trylska
Journal:  Biochimie       Date:  2015-03-03       Impact factor: 4.079

6.  When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy.

Authors:  Moran Shalev; Timor Baasov
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

7.  Electrostatic interactions in aminoglycoside-RNA complexes.

Authors:  Marta Kulik; Anna M Goral; Maciej Jasiński; Paulina M Dominiak; Joanna Trylska
Journal:  Biophys J       Date:  2015-02-03       Impact factor: 4.033

8.  Structural basis for the inhibition of the eukaryotic ribosome.

Authors:  Nicolas Garreau de Loubresse; Irina Prokhorova; Wolf Holtkamp; Marina V Rodnina; Gulnara Yusupova; Marat Yusupov
Journal:  Nature       Date:  2014-09-10       Impact factor: 49.962

9.  Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics.

Authors:  Moran Shalev; Haim Rozenberg; Boris Smolkin; Abedelmajeed Nasereddin; Dmitry Kopelyanskiy; Valery Belakhov; Thomas Schrepfer; Jochen Schacht; Charles L Jaffe; Noam Adir; Timor Baasov
Journal:  Nucleic Acids Res       Date:  2015-08-11       Impact factor: 16.971

10.  Aminoglycoside interactions and impacts on the eukaryotic ribosome.

Authors:  Irina Prokhorova; Roger B Altman; Muminjon Djumagulov; Jaya P Shrestha; Alexandre Urzhumtsev; Angelica Ferguson; Cheng-Wei Tom Chang; Marat Yusupov; Scott C Blanchard; Gulnara Yusupova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

View more
  4 in total

1.  Synthesis of Gentamicin Minor Components: Gentamicin B1 and Gentamicin X2.

Authors:  Parasuraman Rajasekaran; David Crich
Journal:  Org Lett       Date:  2020-04-28       Impact factor: 6.005

2.  Structure-Activity Relationships for 5'' Modifications of 4,5-Aminoglycoside Antibiotics.

Authors:  Jonathan C K Quirke; Girish C Sati; Amr Sonousi; Marina Gysin; Klara Haldimann; Erik C Böttger; Andrea Vasella; Sven N Hobbie; David Crich
Journal:  ChemMedChem       Date:  2022-04-22       Impact factor: 3.540

3.  Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.

Authors:  Jonathan C K Quirke; Parasuraman Rajasekaran; Vikram A Sarpe; Amr Sonousi; Ivan Osinnii; Marina Gysin; Klara Haldimann; Qiao-Jun Fang; Dimitri Shcherbakov; Sven N Hobbie; Su-Hua Sha; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  J Am Chem Soc       Date:  2019-12-17       Impact factor: 15.419

4.  Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying Enzymes.

Authors:  Dimitrijs Lubriks; Rimants Zogota; Vikram A Sarpe; Takahiko Matsushita; Girish C Sati; Klara Haldimann; Marina Gysin; Erik C Böttger; Andrea Vasella; Edgars Suna; Sven N Hobbie; David Crich
Journal:  ACS Infect Dis       Date:  2021-06-11       Impact factor: 5.578

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.